We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+6.69%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$1.38B
AUM Growth
+$46.5M
Cap. Flow
-$32.2M
Cap. Flow %
-2.34%
Top 10 Hldgs %
44.37%
Holding
188
New
7
Increased
57
Reduced
78
Closed
5

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$4.11M
2
UNH icon
UnitedHealth
UNH
+$3.58M
3
IBM icon
IBM
IBM
+$3.24M
4
DD
Du Pont De Nemours E I
DD
+$2.87M
5
BMY icon
Bristol-Myers Squibb
BMY
+$2.74M

Top Sells

Rank Stock Value
1
PAYX icon
Paychex
PAYX
+$11.6M
2
SPGI icon
S&P Global
SPGI
+$9.72M
3
QCOM icon
Qualcomm
QCOM
+$8.34M
4
FAST icon
Fastenal
FAST
+$6.31M
5
OXY icon
Occidental Petroleum
OXY
+$4.61M

Sector Composition

Rank Sector Weight
1 Consumer Staples 33.65%
2 Technology 13.73%
3 Financials 12.56%
4 Healthcare 10.14%
5 Communication Services 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFL icon
26
Aflac
AFL
$63.9B
$10.6M 0.77%
193,960
-10,100
-5% -$521K
LOW icon
27
Lowe's Companies
LOW
$116B
$10.5M 0.76%
103,734
-13,237
-11% -$1.4M
TXN icon
28
Texas Instruments
TXN
$255B
$10.4M 0.76%
90,816
-3,012
-3% -$337K
SBUX icon
29
Starbucks
SBUX
$118B
$10.2M 0.74%
121,410
-40,265
-25% -$3.16M
USB icon
30
US Bancorp
USB
$99.6B
$10.2M 0.74%
193,862
+5,240
+3% +$270K
IBM icon
31
IBM
IBM
$202B
$10.2M 0.74%
77,016
+24,635
+47% +$3.24M
CL icon
32
Colgate-Palmolive
CL
$72.6B
$10.1M 0.73%
141,129
-1,500
-1% -$106K
ADBE icon
33
Adobe
ADBE
$89.5B
$10.1M 0.73%
34,305
-420
-1% -$117K
VZ icon
34
Verizon
VZ
$194B
$10.1M 0.73%
176,155
+5,780
+3% +$333K
CME icon
35
CME Group
CME
$92.2B
$10M 0.73%
51,495
-1,110
-2% -$205K
YUM icon
36
Yum! Brands
YUM
$41B
$9.52M 0.69%
85,985
-12,200
-12% -$1.27M
AMGN icon
37
Amgen
AMGN
$203B
$9.5M 0.69%
51,576
+671
+1% +$120K
MRK icon
38
Merck
MRK
$324B
$9.49M 0.69%
118,587
-7,389
-6% -$566K
CMCSA icon
39
Comcast
CMCSA
$79.1B
$9.29M 0.67%
219,815
-1,400
-0.6% -$59.1K
TFC icon
40
Truist Financial
TFC
$63.2B
$9.06M 0.66%
184,368
+840
+0.5% +$41.1K
MDT icon
41
Medtronic
MDT
$107B
$9.01M 0.65%
92,541
+805
+0.9% +$73.5K
UNP icon
42
Union Pacific
UNP
$183B
$9.01M 0.65%
53,251
-400
-0.7% -$68.5K
STI
43
DELISTED
SunTrust Banks, Inc.
STI
$8.97M 0.65%
142,680
MCD icon
44
McDonald's
MCD
$188B
$8.78M 0.64%
42,258
+2,025
+5% +$401K
CRM icon
45
Salesforce
CRM
$134B
$8.76M 0.64%
57,740
+400
+0.7% +$62.7K
BMY icon
46
Bristol-Myers Squibb
BMY
$127B
$8.66M 0.63%
191,058
+58,901
+45% +$2.74M
HAS icon
47
Hasbro
HAS
$12.6B
$8.48M 0.62%
80,243
+508
+0.6% +$50.1K
PAYX icon
48
Paychex
PAYX
$40.4B
$8M 0.58%
97,194
-137,261
-59% -$11.6M
ETN icon
49
Eaton
ETN
$157B
$7.7M 0.56%
92,429
+22,178
+32% +$1.8M
NKE icon
50
Nike
NKE
$61.9B
$7.67M 0.56%
91,300
+3,325
+4% +$280K

Similar funds

Cullinan Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Cullinan Associates held 188 positions worth $1.38B, up 3.5% from $1.33B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cullinan Associates's Q2 2019 filing shows 7 new, 57 increased, 78 reduced and 5 closed positions. Its largest new stake was Du Pont De Nemours E I: 38,291 shares worth $2.87M. The largest sale was Paychex, an estimated $11.6M.

By sector, the portfolio is most concentrated in Consumer Staples at 34% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

  • Cullinan Associates's largest Q2 2019 buy was Du Pont De Nemours E I: 38,291 shares worth $2.87M.
  • Cullinan Associates added most to DuPont de Nemours in Q2 2019, an estimated $4.11M increase.
  • Cullinan Associates's biggest Q2 2019 reduction was Paychex, cutting an estimated $11.6M.
  • Cullinan Associates fully exited Occidental Petroleum in Q2 2019, selling an estimated $4.61M.
  • Cullinan Associates's ten largest holdings make up 44% of its $1.38B portfolio in Q2 2019.
  • Cullinan Associates opened 7 new positions and closed 5 in Q2 2019.
  • Cullinan Associates's portfolio value rose 3.5% quarter-over-quarter to $1.38B.

Based on Cullinan Associates's 13F filing for Q2 2019, filed 16 Jul 2019.